(May 2015_ March 2016)
Pap Smear Test
Cervical cancer is the third most diagnosed cancer and the fourth leading cause of cancer death among women worldwide accounting for 9% of all malignancies among females in 2008. More than 85% of the cervical cancer cases occur in developing countries where public health infrastructure does not support Papanicolaou testing. In countries with developed healthcare systems, widespread cervical screening programmers, aimed at detecting precancerous changes that can then be treated to prevent invasive cancer, have significantly reduced the number of deaths from the disease. The Papanicolaou (Pap) smear, is the primary screening test for cervical cancer. It has been largely responsible for diagnosing cancerous and precancerous lesions in many developed countries.
Automated screening
Automated screening machines can analyses Pap smear slides in a short time without fatigue, providing consistent and objective classification results. The rationale for automated screening is to improve the limitations of the conventional Pap smear test in the following ways:
Aim and objectives
The aim of this project was to fully explore the structural approach to chromatin pattern description and to evaluate the efficacy of the features derived from it for discriminating between normal and abnormal Pap slides. The project had the following objectives:
Scope
The proposed cervical screening approach has the following steps:
Preprocessing
The image preprocessing stage is required when segmenting the cell for background extraction. Every captured image exhibits a certain percentage of noise and may have low contrast. Overall, most methods start by reducing noise and increasing contrast. Median filters are traditionally used to reduce noise, where the gray level of every pixel is replaced by the median of the intensity levels of the pixel neighborhood.
Segmentation
This chapter deals specially with the problem of accurately and robustly segmenting the cervical cell nuclei in digitized light microscopy images of Pap smears.
Feature Extraction
This section deals with the problem of quantitative characterization of chromatin texture and presents a set of novel structural texture features to describe nuclear chromatin patterns in cells on a conventional Pap smear. These features are derived from a segmentation of the chromatin into blob-like primitives. The proposed set of features are, in particular, derived from statistics of morphometric features and contextual features computed for these blobs.
Feature Analysis and Selection
This section presents an evaluation of the performance of the proposed structural chromatin texture features. In particular, it presents an investigation of the most discriminatory subset of features, from among the proposed features and a wide range of features drawn from the literature, for discriminating between normal and abnormal Pap smears. The section presents the details of the two experiments carried out in this project. The first is a feature selection experiment performed to obtain the most discriminatory subset of features. The second experiment is to evaluate the performance of a variety of classifiers built using the feature subset obtained in the first experiment to discriminate between the normal and abnormal slides.
Classification
In this step we need to assign an object to a specific category from a variety of different categories based on some special characteristics of that object. As a case in point, in this project we want to categorize a particular Pap slide as either normal or abnormal. In computer science, these kind of situations are described as classification problems.
Normal: columnar epithelial, parabasal squamous epithelial, intermediate squamous epithelial, superficial squamous epithelial.
Abnormal: mild squamous non-keratinizing dysplasia, moderate squamous non-keratinizing dysplasia, severe squamous non-keratinizing dysplasia.
Collaborator:
Dr.Mansoor Fatehi
Director, Medical Imaging Informatics Research Center at Tehran
Chairman of the Board, Sorenahealth, Iranian Modern Health Strategies
Doctorate in Clinical Laboratory Science
Iranian Association of Clinical Laboratory Doctors